New Drug Approvals
March 8th, 2010
A new drug has been developed, called alitretinoin, which can help clear up severe hand eczema and relieve cracked, itchy, and irritated hands, research reports.
March 5th, 2010
A new drug, awaiting FDA approval, is showing promise for lengthening the lives of men who have advanced prostate cancer and have run out of treatment options
December 21st, 2009
The prescription drug Aricept, used to treat the dementia that results from Alzheimer’s disease, has had a new generic version approved by the U.S. Food and Drug Administration. This version, to be made available at every Online Canadian Pharmacy, will dissolve instantly on the tongue.
There are already other versions of Aricept on the market that [...]
December 18th, 2009
FDA regulators have approved a newly developed version of the anti-psychotic drug Zeprexa, this longer-lasting version will be manufactured by Eli Lilly & Co.
The Food and Drug Administration allowed for the distribution of Zyprexa Relprevv in the form of an injection. It will be used for the treatment of schizophrenia in adults and can last [...]
November 20th, 2009
In the past, it was thought that a person’s genetic makeup affected how they reacted to different asthma medications, now a new study is revealing that most people can benefit from a certain combination treatment regardless of their genes.
These genes are related to a receptor in the body that is important in the effectiveness of [...]
August 19th, 2009
Although, prGCD, a new drug used to treat patients with a unique genetic disorder - Gaucher disease, has not received full market approval, the U.S. FDA has said that physicians may utilize the drug for treatment.
August 17th, 2009
Novartis has recently announced the U.S. FDA approval of their multiple sclerosis treatment drug: Extavia (Interferon beta 1-b). The FDA approved the drug for patients that suffer from a relapse of the auto immune disease, or for those patients whom are newly diagnosed with MS.
August 17th, 2009
The US FDA has approved Saphris sublingual tablets for the acute therapy of schizophrenic adults, as well as the acute therapy of manic or mixed bipolar I disorder, with or without adult psychotic attributes. Saphris is endorsed for first-line therapy, and is the first prescription drug to receive primary consent for both of these symptoms concurrently.
August 7th, 2009
Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine. Currently, Baxter is discussing distribution options with national health authorities, so long as they receive appropriate permission. Baxter implemented their proprietary Vero cell production technology when developing CELVAPAN.
August 7th, 2009
Recently, the US FDA has approved a once-daily tablet to treat adult Type 2 Diabetes. Along with diet and exercise, Onglyza will assist to manage high blood sugar levels.
